Dose Calibrator Constancy Failure Before a Pediatric Study
A nuclear pharmacy performs its daily dose-calibrator constancy test at 07:00 using a Cs-137 reference source. The measured value is 8% below the expected value; the facility's action limit is ±5%. The staff technologist notes that the previous day's test was within 2%. A 6-year-old patient is scheduled at 09:00 for a Tc-99m DMSA renal scan, and the prescribed activity is 1.5 MBq/kg; the child weighs 20 kg. The only other dose calibrator in the building is in a different department and has not been cross-calibrated with this one. The pharmacist is asked whether to proceed.
1. What is the appropriate immediate action regarding the dose calibrator, and why does an 8% deviation matter for this particular patient?
Read the worked answer
The calibrator must be removed from service for patient-dose measurement until the discrepancy is investigated and corrected. An 8% deviation exceeds the facility's ±5% action limit and is a constancy failure.
Why it matters here:
- Pediatric dosing is weight-based and low-activity. The prescribed activity is 1.5 MBq/kg × 20 kg = 30 MBq. A systematic 8% error means the measured activity could differ from the true activity by ~2.4 MBq - a meaningful fraction of a small pediatric dose.
- Diagnostic image quality and radiation burden both depend on accurate activity; an under-read could lead to administering more activity than intended, and an over-read to under-dosing and a nondiagnostic scan.
- Regulatory expectation: constancy failures require investigation (source geometry, source decay correction, background, voltage drift, shielding) and documentation before the calibrator is returned to service.
Immediate steps: repeat the test with correct source positioning and background subtraction; check whether the Cs-137 source is past its calibration date; if the failure persists, arrange for repair/calibration and use an alternative validated method for the patient's dose.
2. The 09:00 study cannot be postponed. The pharmacist considers using the other department's calibrator. What must be confirmed before that instrument can be used, and how should the pediatric dose be prepared and verified?
Read the worked answer
Before using the alternate calibrator, the pharmacist must confirm:
- It is currently within its own constancy and accuracy checks (daily constancy, and annual accuracy/precision/linearity/geometry as applicable).
- Cross-calibration between the two instruments - measure the same source on both and document agreement within the facility's tolerance. Using an uncross-calibrated instrument simply substitutes one unknown bias for another.
- Geometry and volume correction - the pediatric dose is small-volume; the calibrator's geometry response must be appropriate for the vial/syringe used.
Preparation and verification of the dose:
- Calculate the prescribed activity: 1.5 MBq/kg × 20 kg = 30 MBq at the scheduled administration time.
- Assay the prepared syringe on the validated calibrator, decay-correct to administration time, and confirm the activity is within the facility's acceptable range (commonly ±10% of prescribed).
- Have a second qualified person independently verify the calculation and the assay.
- Document the calibrator failure, the alternate instrument used, the cross-calibration result, and the final assayed activity in the patient record.